258 related articles for article (PubMed ID: 8707954)
21. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
22. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
23. [Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].
Yoshikawa H; Ikeuchi T; Iguchi H; Onodera Y; Kai Y
Hinyokika Kiyo; 1995 Apr; 41(4):253-8. PubMed ID: 7785554
[TBL] [Abstract][Full Text] [Related]
24. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
25. Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2.
Sakr SA; Mahran HA; Fahmy AM; El-Kholy MA; Meawad M
Biomed Pharmacother; 2015 Dec; 76():73-81. PubMed ID: 26653553
[TBL] [Abstract][Full Text] [Related]
26. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
29. The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium.
Lin Z; Kim H; Park H; Kim Y; Cheon J; Kim I
Urol Res; 2003 Aug; 31(4):272-5. PubMed ID: 12879322
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder.
Iizumi T; Iiyama T; Tanaka W; Okada E; Kamiyama Y; Okano Y; Sato S; Yazaki T; Umeda T; Imamura T
Urol Int; 1997; 59(2):81-7. PubMed ID: 9392054
[TBL] [Abstract][Full Text] [Related]
31. Expression of bcl-2 and bcl-X in bladder cancer.
Kirsh EJ; Baunoch DA; Stadler WM
J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
[TBL] [Abstract][Full Text] [Related]
32. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
Chen L; Wang X; Mei H; Chen W
Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of p53 and bcl-2.
Amirghofran Z; Monabati A; Khezri A; Malek-Hosseini Z
Pathol Oncol Res; 2004; 10(3):154-8. PubMed ID: 15448751
[TBL] [Abstract][Full Text] [Related]
34. p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.
Wu TT; Lee YH; Huang JK
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):9-14. PubMed ID: 11310375
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder.
Atuğ F; Türkeri L; Ozyürek M; Akdaş A
Int Urol Nephrol; 1998; 30(4):455-61. PubMed ID: 9821049
[TBL] [Abstract][Full Text] [Related]
36. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
Kalantari MR; Ahmadnia H
Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
[TBL] [Abstract][Full Text] [Related]
37. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
[TBL] [Abstract][Full Text] [Related]
38. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
Tiniakos DG; Mellon K; Anderson JJ; Robinson MC; Neal DE; Horne CH
Br J Urol; 1994 Dec; 74(6):757-61. PubMed ID: 7827848
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
40. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.
Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A
Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
